Serotoninergic involvement in the cimetidine-induced prolactin release

Area of Science:

• Neuroendocrinology
• Pharmacology
• Reproductive Biology

Background:

• Histamine H1 and H2 receptors in the brain influence anterior pituitary secretion.
• H2 receptor antagonists like cimetidine are known to stimulate prolactin (PRL) release.
• Serotoninergic pathways are recognized for their role in PRL secretion.

Purpose of the Study:

• To investigate the involvement of serotoninergic pathways in the PRL-releasing action of cimetidine.
• To examine the ontogeny and sex differences in cimetidine's effect on PRL secretion.
• To elucidate the mechanism by which cimetidine stimulates PRL release.

Main Methods:

• Determined the PRL-releasing effect of cimetidine in developing male and female rats of various ages.
• Administered serotonin receptor blocker (methysergide) and serotonin synthesis inhibitor (p-chlorophenylalanine) to adult male rats.
• Measured PRL levels and indole content in specific brain regions after drug administration.
• Assessed the effect of cimetidine, methysergide, and serotonin on serum luteinizing hormone (LH) levels.

Main Results:

• Cimetidine induced PRL release in rats from 12 days of age, with greater response in males at 20 and 28 days.
• The developmental pattern of cimetidine's action mirrored that of serotoninergic control of PRL secretion.
• Methysergide and p-chlorophenylalanine blocked cimetidine-induced PRL release, indicating serotonin's crucial role.
• Neither cimetidine, methysergide, nor serotonin affected serum LH levels.

Conclusions:

• A significant serotoninergic input is involved in the prolactin-releasing effect of cimetidine.
• The findings highlight the interplay between histamine and serotonin systems in regulating PRL secretion.
• The study provides evidence for a specific neurochemical pathway mediating cimetidine's endocrine effects.